Marius Ringelstein Selected Research

Marius Ringelstein Research Topics

Disease

24	Neuromyelitis Optica (Devic's Disease) 01/2022 - 01/2012
13	Multiple Sclerosis 11/2021 - 01/2012
12	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 01/2012
8	Ganglion Cysts (Ganglion) 01/2022 - 01/2012
7	Myelitis 09/2020 - 07/2015
5	Encephalitis (Encephalitis, Rasmussen) 11/2021 - 01/2016
5	Susac Syndrome 12/2016 - 01/2012
4	Autoimmune Diseases of the Nervous System 11/2021 - 01/2018
3	Pain (Aches) 01/2022 - 07/2015
3	Atrophy 01/2022 - 07/2017
3	Infections 11/2021 - 01/2012
3	Leukocytosis (Pleocytosis) 11/2016 - 01/2012
3	Relapsing-Remitting Multiple Sclerosis 04/2016 - 01/2012
2	Infarction (Infarctions) 03/2022 - 08/2015
2	Disease Progression 03/2022 - 07/2017
2	Inflammation (Inflammations) 01/2022 - 11/2021
2	Polyneuropathies (Polyneuropathy) 01/2022 - 10/2016
2	Rubella (German Measles) 09/2020 - 09/2020
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 09/2020 - 09/2020
2	Encephalomyelitis (Myeloencephalitis) 09/2020 - 09/2020
2	Herpes Zoster 09/2020 - 09/2020
2	Measles 09/2020 - 09/2020
2	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 03/2013
2	Neoplasms (Cancer) 01/2019 - 10/2016
2	Vision Disorders (Hemeralopia) 11/2016 - 09/2015
2	Transverse Myelitis (Necrotizing Myelitis) 01/2016 - 12/2014
2	Retinal Artery Occlusion 08/2015 - 06/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 07/2015 - 11/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2022
1	Seizures (Absence Seizure) 03/2022
1	Stiff-Person Syndrome (Stiff Man Syndrome) 03/2022
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2022
1	Ataxia (Dyssynergia) 03/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022
1	Epilepsy (Aura) 03/2022
1	Diabetes Mellitus 03/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	COVID-19 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2022
1	Glioma (Gliomas) 11/2021
1	Central Nervous System Infections (Central Nervous System Infection) 11/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Birth Weight (Birth Weights) 01/2020
1	Headache (Headaches) 10/2019
1	Convalescence 01/2019
1	Sepsis (Septicemia) 01/2019
1	Sarcoidosis (Schaumann Disease) 11/2018
1	Papilledema 07/2017
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 07/2017

Drug/Important Bio-Agent (IBA)

17	Retinaldehyde (Retinal)IBA 01/2022 - 01/2012
12	Immunoglobulin G (IgG)IBA 01/2022 - 07/2014
10	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2016
9	AntibodiesIBA 11/2021 - 01/2012
7	Oligoclonal BandsIBA 01/2022 - 01/2012
5	AutoantibodiesIBA 03/2022 - 10/2016
4	tocilizumab (atlizumab)FDA Link 01/2022 - 03/2013
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2018
3	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022 - 03/2013
3	Leucine (L-Leucine)FDA Link 11/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2020
3	anti-aquaporin 4 autoantibodyIBA 07/2017 - 01/2012
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2022 - 11/2021
2	Immunoglobulin M (IgM)IBA 09/2020 - 09/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2020 - 09/2020
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 09/2020
2	AlbuminsIBA 09/2020 - 09/2020
2	Immunoglobulin A (IgA)IBA 09/2020 - 09/2020
2	Immunoglobulin IsotypesIBA 09/2020 - 09/2020
2	Monoclonal AntibodiesIBA 01/2020 - 03/2013
2	Natalizumab (Tysabri)FDA Link 01/2020 - 07/2017
2	Aquaporin 4IBA 07/2015 - 03/2013
2	Aquaporins (Water Channels)IBA 04/2014 - 03/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2022
1	Protein Isoforms (Isoforms)IBA 03/2022
1	CreatinineIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	Tirofiban (Aggrastat)FDA Link 03/2022
1	dimemorfan (AT 17)IBA 01/2022
1	CytokinesIBA 01/2022
1	Complement System Proteins (Complement)IBA 11/2021
1	Complement C3 (C3 Complement)IBA 11/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Pain-FreeIBA 01/2021
1	ocrelizumabIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2019
1	Alemtuzumab (Campath)FDA Link 11/2018

Therapy/Procedure

6	Immunotherapy 03/2022 - 01/2017
4	Therapeutics 03/2016 - 12/2014
2	Plasma Exchange 11/2018 - 11/2016
1	Punctures 03/2022
1	Stents 03/2022
1	Thrombectomy 03/2022
1	Activities of Daily Living (ADL) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Tracheostomy 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Blood Component Removal (Apheresis) 11/2018